News About: Pharm. Industry
KoreaBio’s opposition to KPMA’s use of word ‘Bio’ in their name
On the 22nd, the Korea Biotechnology Industry Organization(President Jeong-Sun Seo, hereinafter referring to KoreaBio) officially announced an opinion of opposing the Korea Pharmaceutical Manufacturers Association(KPM...
8 Korean pharmas incremented in bidding grade with PIC/S membership
The Ministry of Food and Drug Safety(MFDS) announced on the 22nd the Vietnamese government has incrementally adjusted the public bidding grade for Korean pharmaceutical companies’ generic products, which will be suppl...
Kyeong-Ho Lee, “I’ll always cheer for improvement of the Korean pharmaceutical industry ”
Korea Pharmaceutical Manufacturers Association(KPMA) Chairman Kyeong-Ho Lee, who will leave the association at the end of February after the 6 years of service, delivered a message to the member companies, “I’ll alway...
Yuhan and Chong Kun Dang having ‘best’ operating performance among ‘Big5’ pharmas
Among the ‘Big5’ pharmaceutical companies, companies which were evaluated excellent in operating performance were Yuhan Corporation and Chong Kun Dang.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result...
Celltrion acquires approval of world’s first anticancer antibody biosimilar ‘Truxima’
Celltrion announced on the 22nd that Truxima(generic name: rituximab), an antibody biosimilar for the treatment of hematologic malignancy and autoimmune disease, has acquired sales approval from the European Medicines...
Gilead Sciences launch one-pill, combination HIV treatment ‘Genvoya’
‘Genvoya,’ a one-pill, combination HIV treatment containing TAF(Tenofovir Alafenamide) for the first time, will be launched in Korea from February.
Tenofovir Alafenamide shows the antiviral effect that is similar to ...
Only did 4 pharmas declare over KRW 10 billion cash dividends
It was observed 4 pharmaceutical companies, including Yuhan Corporation, have declared KRW 10 billion cash dividends for the operating performance of 2016.
As of the 21st of February, there were only 4 companies(Yuh...
Entire Seoul Western DPO’s rebate investigation team extended in term of office
The prosecution was expected to carry out the rebate investigation on pharmaceutical companies.
It was told the entire personnel at the Food and Drug Investigation Team under the Seoul Western District Prosecutors’ O...
Huons Global recruits Moon-Jung Lim, PhD, former director of Dong Wha Pharm Research Center as director of Humedix Research Center
Huons Global announced recruitment of Moon-Jung Lim(55), PhD, a former director of Dong Wha Pharm, as a director of Humedix Research Center.
Director Moon-Jung Lee received the bachelor and master degrees at Chungbuk...
Hanmi becomes pharma having the highest No. of overseas new drug pipelines
It was observed Hanmi Pharm was the Korean pharmaceutical company which has the highest number of new drug pipelines in progress of overseas clinical trial.
According to the status of Korean pharmaceutical companies’...
